Commentaries in HL

Relapse After Transplant: Next Steps for Patients with Hodgkin Lymphoma
Relapse After Transplant: Next Steps for Patients with Hodgkin Lymphoma
CME, CPE
Alison Moskowitz, MD
Release Date: October 19, 2016
Expiration Date: October 19, 2017

Patients with Hodgkin lymphoma (HL) who relapse after stem cell transplantation require accurate assessment of disease to develop realistic treatment goals and devise an appropriate therapeutic strategy. In this activity, Dr. Alison J. Moskowitz, Clinical Director of the Lymphoma Inpatient Unit at Memorial Sloan Kettering Cancer Center, reviews methods for prognosticating patients who relapse after transplant, as well as treatment options based on a combination of patient-related factors, disease biology, and practical treatment goals.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Takeda Oncology

Begin, Earn CreditView Only, No Credit
 
A Practical Guide to PET-Adapted Therapy for Hodgkin Lymphoma
A Practical Guide to PET-Adapted Therapy for Hodgkin Lymphoma
CME, CPE
Peter Johnson, MD
Release Date: September 28, 2016
Expiration Date: September 28, 2017

Adaptive treatment strategies in Hodgkin lymphoma (HL) have the potential to individualize therapy through outcomes-based modifications. In this activity, Dr. Peter Johnson, Professor of Medical Oncology at the University of Southampton in the United Kingdom, discusses the current landscape of positron emission tomography (PET)-adapted therapy, including investigational treatment pathways and their impact on response rates and survival outcomes. In addition, Dr. Johnson will describe the utility of interim PET among currently recognized prognostic factors to help providers understand the practical application of PET-adapted therapy.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Takeda Oncology

Begin, Earn CreditView Only, No Credit
 
Aiming for a Higher Cure Rate: Strategies for Salvage Treatment at Relapse in HL
Aiming for a Higher Cure Rate: Strategies for Salvage Treatment at Relapse in HL
CME, CPE
Robert W. Chen, MD
Release Date: February 17, 2016
Expiration Date: February 17, 2017

Join Robert Chen, MD, of the Department of Hematology/HCT at the City of Hope Medical Center for a discussion regarding the latest strategies for salvage therapy at relapse in Hodgkin lymphoma.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Takeda Oncology
View Only, CE ExpiredView Only, No Credit
 

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2017 MediCom Worldwide, Inc. All rights reserved